These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37977244)

  • 21. Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.
    Lefere S; Tacke F
    JHEP Rep; 2019 May; 1(1):30-43. PubMed ID: 32149275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits.
    Peiseler M; Schwabe R; Hampe J; Kubes P; Heikenwälder M; Tacke F
    J Hepatol; 2022 Oct; 77(4):1136-1160. PubMed ID: 35750137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of chronic inflammation in the pathogenesis of nonalcoholic steatohepatitis: lessons from a unique mouse model using melanocortin receptor-deficient mice.
    Itoh M; Suganami T; Ogawa Y
    Endocr J; 2021 Jul; 68(7):743-749. PubMed ID: 33967185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble TREM2 levels reflect the recruitment and expansion of TREM2
    Hendrikx T; Porsch F; Kiss MG; Rajcic D; Papac-Miličević N; Hoebinger C; Goederle L; Hladik A; Shaw LE; Horstmann H; Knapp S; Derdak S; Bilban M; Heintz L; Krawczyk M; Paternostro R; Trauner M; Farlik M; Wolf D; Binder CJ
    J Hepatol; 2022 Nov; 77(5):1373-1385. PubMed ID: 35750138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
    Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
    Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue.
    Falkevall A; Mehlem A; Folestad E; Ning FC; Osorio-Conles Ó; Radmann R; de Hollanda A; Wright SD; Scotney P; Nash A; Eriksson U
    J Hepatol; 2023 May; 78(5):901-913. PubMed ID: 36717026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver.
    AlAsfoor S; Rohm TV; Bosch AJT; Dervos T; Calabrese D; Matter MS; Weber A; Cavelti-Weder C
    Sci Rep; 2018 Oct; 8(1):15331. PubMed ID: 30333571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice.
    Ni XX; Ji PX; Chen YX; Li XY; Sheng L; Lian M; Guo CJ; Hua J
    Liver Int; 2022 Dec; 42(12):2696-2712. PubMed ID: 36165186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease.
    Cimini FA; Barchetta I; Ciccarelli G; Leonetti F; Silecchia G; Chiappetta C; Di Cristofano C; Capoccia D; Bertoccini L; Ceccarelli V; Carletti R; Fraioli A; Baroni MG; Morini S; Cavallo MG
    Diabetes Metab Res Rev; 2021 Jan; 37(1):e3358. PubMed ID: 32469428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophages as Key Players during Adipose Tissue-Liver Crosstalk in Nonalcoholic Fatty Liver Disease.
    Korf H; Boesch M; Meelberghs L; van der Merwe S
    Semin Liver Dis; 2019 Jul; 39(3):291-300. PubMed ID: 31041786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages.
    Drummer C; Saaoud F; Jhala NC; Cueto R; Sun Y; Xu K; Shao Y; Lu Y; Shen H; Yang L; Zhou Y; Yu J; Wu S; Snyder NW; Hu W; Zhuo J'; Zhong Y; Jiang X; Wang H; Yang X
    Front Immunol; 2023; 14():1113883. PubMed ID: 36776889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression.
    Guillot A; Winkler M; Silva Afonso M; Aggarwal A; Lopez D; Berger H; Kohlhepp MS; Liu H; Özdirik B; Eschrich J; Ma J; Peiseler M; Heymann F; Pendem S; Mahadevan S; Gao B; Diehl L; Gupta R; Tacke F
    Hepatology; 2023 Jul; 78(1):150-166. PubMed ID: 36630995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis.
    Ni Y; Zhuge F; Nagashimada M; Ota T
    Nutrients; 2016 Jun; 8(7):. PubMed ID: 27347998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osr1 Regulates Macrophage-mediated Liver Inflammation in Nonalcoholic Fatty Liver Disease Progression.
    Liu L; Zhou Y; Liu Z; Li J; Hu L; He L; Gao G; Kidd B; Walsh A; Jiang R; Wu C; Zhang K; Xie L
    Cell Mol Gastroenterol Hepatol; 2023; 15(5):1117-1133. PubMed ID: 36581078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic differences in intra-abdominal adipose tissue in extremely obese adolescents with different stages of NAFLD.
    Sheldon RD; Kanosky KM; Wells KD; Miles L; Perfield JW; Xanthakos S; Inge TH; Rector RS
    Physiol Genomics; 2016 Dec; 48(12):897-911. PubMed ID: 27764764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet.
    Pilling D; Karhadkar TR; Gomer RH
    PLoS One; 2020; 15(12):e0244762. PubMed ID: 33378413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice.
    Wu Z; Xu J; Tan J; Song Y; Liu L; Zhang F; Zhang Y; Li X; Chi Y; Liu Y
    J Cell Mol Med; 2019 May; 23(5):3375-3385. PubMed ID: 30772951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease.
    Nati M; Chung KJ; Chavakis T
    J Innate Immun; 2022; 14(1):31-41. PubMed ID: 34515137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.